State Street’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-171,566
| Closed | -$149K | – | 4663 |
|
|
2023
Q2 | $149K | Hold |
171,566
| – | – | ﹤0.01% | 4095 |
|
|
2023
Q1 | $120K | Hold |
171,566
| – | – | ﹤0.01% | 4262 |
|
|
2022
Q4 | $141K | Hold |
171,566
| – | – | ﹤0.01% | 4247 |
|
|
2022
Q3 | $178K | Hold |
171,566
| – | – | ﹤0.01% | 4207 |
|
|
2022
Q2 | $281K | Sell |
171,566
-413,834
| -71% | -$859K | ﹤0.01% | 4064 |
|
|
2022
Q1 | $1.72M | Buy |
585,400
+9,501
| +2% | +$33.3K | ﹤0.01% | 3624 |
|
|
2021
Q4 | $2.75M | Buy |
575,899
+72,666
| +14% | +$469K | ﹤0.01% | 3536 |
|
|
2021
Q3 | $3.81M | Buy |
503,233
+66,905
| +15% | +$428K | ﹤0.01% | 3368 |
|
|
2021
Q2 | $3.25M | Buy |
436,328
+418,328
| +2,324% | +$3.22M | ﹤0.01% | 3432 |
|
|
2021
Q1 | $140K | Buy |
18,000
+1,400
| +8% | +$14K | ﹤0.01% | 3876 |
|
|
2020
Q4 | $153K | Hold |
16,600
| – | – | ﹤0.01% | 3778 |
|
|
2020
Q3 | $115K | Buy |
+16,600
| New | +$101K | ﹤0.01% | 3707 |
|
|
2019
Q4 | – | Sell |
-12,724
| Closed | -$18K | – | 3834 |
|
|
2019
Q3 | $18K | Buy |
12,724
+476
| +4% | +$1.04K | ﹤0.01% | 3769 |
|
|
2019
Q2 | $35K | Sell |
12,248
-121,447
| -91% | -$483K | ﹤0.01% | 3744 |
|
|
2019
Q1 | $638K | Sell |
133,695
-18,152
| -12% | -$89.3K | ﹤0.01% | 3415 |
|
|
2018
Q4 | $644K | Buy |
151,847
+25,897
| +21% | +$200K | ﹤0.01% | 3410 |
|
|
2018
Q3 | $1.38M | Buy |
125,950
+28,888
| +30% | +$338K | ﹤0.01% | 3352 |
|
|
2018
Q2 | $1.58M | Buy |
+97,062
| New | +$1.4M | ﹤0.01% | 3333 |
|
State Street's SURF Position: Q3 2023 in Review
State Street sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 171,566 shares — an estimated $149K sold.
State Street first reported a position in SURF in Q2 2018 and held it in 18 quarters. The position peaked at $3.81M in Q3 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.
- State Street reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- State Street sold 171,566 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $149K.
- State Street first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
- State Street's Surface Oncology, Inc. Common Stock position peaked at $3.81M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.
Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.